Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

AMRI riding high on API acquisitions, expects more M&A to come

AMRI attributed a robust first quarter to its growing API business and recent acquisitions, and says to expect more M&A activity this year.

Despite recent site closure, AMRI looking to acquire API plants

Study finds targeting HDAC enzymes could offer hope against Alzheimer’s

A new study is shaking up ideas about a known therapeutic strategy for Alzheimer’s disease, following a discovery by scientists at Scripps Research Institute testing enzyme inhibitors.

Capsugel focusing on inhaled biotherapeutics from Bend facility

Capsugel says it is bolstering its service to offer specialised dry powder inhalation (DPI) formulations, allowing biotherapeutics to be delivered to the lung rather than by injection.

Three-way collaboration to offer packaging serialisation ahead of EU Directive

Schott, Heuft and GEA have teamed up to offer drugmakers a serialisation service for primary packaging to help with EU anti-counterfeiting requirements.

IPEC says confusion around FDA review of excipients could delay ANDA review cycles

Inaccurate and incomplete information on excipients referenced in the US FDA Inactive Ingredient Database (IID), as well as other agency policies and guidance on the review of inactive ingredients in ANDAs (Abbreviated New Drug Applications) “continue to create confusion for the pharmaceutical industry,” according to a position paper from IPEC-Americas...

API firms stand to gain by seeking prequalification says the WHO

Persuading API manufacturers to seek prequalification is a challenge according to the WHO, which wants to raise awarness about the process and the positive impact it has on a suppliers' reputation.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...